BioRestorative Therapies Emerges from Chapter 11 Reorganization
MELVILLE, N.Y., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences...
Month: November 2020
Baudax Bio Announces Publication of ANJESO® Network Meta-Analysis in the Peer-Reviewed Journal BMC Anesthesiology
ANJESO Found to Provide Superior Pain Relief with Similar or Better Safety Compared to Other Approved IV Non-Opioid Analgesics MALVERN,...
Trevena, Inc. Announces Publication Highlighting GI Tolerability Profile of OLINVYK™ (oliceridine) injection in Pain and Therapy
-- OLINVYK significantly reduced risk of vomiting and rescue antiemetic use compared to IV morphine in a retrospective analysis --...
Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine
In addition to today’s submission to the FDA, the companies have already initiated rolling submissions across the globe including in...
Burning Rock Reports Third Quarter 2020 Financial Results
GUANGZHOU, China, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a...
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Congenica Appoints Dr. Sam Roberts as Non-Executive Director Cambridge, United Kingdom – 20 November 2020 - Congenica, the digital health...
Nyxoah to Participate in Annual Piper Sandler Healthcare Conference
PRESS RELEASE Nyxoah to Participate in Annual Piper Sandler Healthcare Conference Mont-Saint-Guibert, Belgium – 20th November 2020 – Nyxoah...
Kiadis issues options to newly hired employees to meet its existing obligations
This is a press release by Kiadis Pharma N.V. (Kiadis), pursuant to the provisions of Sections 5 paragraphs 4 and...
Nxt-Id, Inc. to Adjourn Annual Meeting of Stockholders
OXFORD, CONNECTICUT, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Nxt-ID, Inc. (NASDAQ: NXTD) (the “Company”) today announced that the Company plans...
Pixium Vision receives French regulatory authority (ANSM) approval to initiate European PRIMAvera pivotal study of Prima System
Pixium Vision receives French regulatory authority (ANSM) approval to initiate European PRIMAvera pivotal study of Prima System Paris, November 20,...
Maravai LifeSciences Announces Pricing of an Upsized Initial Public Offering
SAN DIEGO, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of...
Sotera Health Announces Pricing of Initial Public Offering
CLEVELAND, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Sotera Health Company today announced the pricing of its initial public offering (“IPO”)...
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
Significant Reduction in Triglyceride Levels Without Low-Density Lipoprotein Cholesterol (LDL-C) Increase Compared to Placebo and Safety Profile Similar to Placebo...
Operational and Financial Results for the Period Ended September 30, 2020
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory...
Aurora Spine Corporation Announces Financial Results for Third Quarter
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Gross margin improves to 48%, revealing company...
Kane Biotech to Release Third Quarter 2020 Financial Results on November 26 – Conference Call to Follow
WINNIPEG, Manitoba, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a...
LifeLabs reports surpassing 800,000 COVID-19 molecular tests
Toronto, Nov. 19, 2020 (GLOBE NEWSWIRE) -- LifeLabs is pleased to report results of over 800,000 COVID-19 molecular diagnostic tests...
Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L
Initial Focus on Acute Respiratory Distress Syndrome, including COVID-19 NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;...
MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics
WESTLAKE VILLAGE, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it has achieved the final development...
Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy
Novartis enters into exclusive worldwide license with Mesoblast to develop, commercialize and manufacture remestemcel-L for treatment of acute respiratory distress...